I-MAB

$37.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (+0.40%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell I-MAB and other stocks, options, and ETFs commission-free!

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company. It engages in the development and commercialization of biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China. The listed name for IMAB is I-MAB American Depositary Shares.

CEO
Hua Qiong Shen
Employees
185
Headquarters
Pudong, Shanghai
Founded
2016
Market Cap
2.68B
Price-Earnings Ratio
Dividend Yield
Average Volume
189.89K
High Today
$38.27
Low Today
$37.23
Open Price
$37.84
Volume
242.60K
52 Week High
$47.46
52 Week Low
$9.30

Collections

IMAB Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Expected Mar 31, Pre-Market

You May Also Like